1Y Target$21.49Near-term target
5Y Target$32.02Compound horizon
10Y Target$83.32Long-dated conviction
FCF$1mTTM · 03/26C-FCF $1m — barely positive; fragile cash position · TTM computed from 4 most-recent quarters (TTM · 03/26).
Rev+7.8%TTM YoYBRevenue +7.8% — at or above S&P median · TTM YoY from trailing-4-quarter revenue sum vs prior 4 quarters.
D/E0.79BD/E 0.79 — at market average, manageable
P/S1.1xA-P/S 1.1x — cheap for any tech/growth name
PEG—proxy—PEG not meaningful — earnings growth negative or data unavailable · PEG proxy: P/E ÷ revenue growth % (true PEG requires forward EPS estimates, not in Finnhub free tier).
Why now
Health Care · market cap $5.7b. 16% off the 52-week high of $18.91.
Moat
Speculative bucket — the moat thesis is forward-looking; without proven margin structure or capital efficiency yet, the durability argument is about IP / network effects / first-mover position that the company hasn't fully monetized.
Risk
Currently unprofitable (margin -4.2%) — path to GAAP profitability is the core thesis risk. ROE -3% is below the long-run sustainable threshold of ~10% — capital efficiency would need to improve for the equity base to compound at the market rate.
Horizon
1-3 yr $21.49 (structural (no analyst coverage)) — catalyst-driven; binary events dominate. 5 yr $32.02 — requires the platform / technology to reach commercial scale. 10 yr $83.32 — return distribution heavily skewed.
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See
terms and
methodology for full disclosures.